Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden
· Delayed Price · Currency is SEK 92.00
-1.20 (-1.29%)
Apr 29, 2026, 1:16 PM CET
Devyser Diagnostics AB Market Cap
Devyser Diagnostics AB has a market cap or net worth of 1.56 billion as of April 29, 2026. Its market cap has increased by 3.98% in one year.
Market Cap
1.56B
Enterprise Value
1.54B
Revenue
257.50M
Ranking
n/a
PE Ratio
104.17
Stock Price
92.00
Market Cap Chart
Since December 10, 2021, Devyser Diagnostics AB's market cap has increased from 1.35B to 1.56B, an increase of 15.75%. That is a compound annual growth rate of 3.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 1.56B | -17.73% |
| Dec 30, 2025 | 1.90B | -2.79% |
| Dec 30, 2024 | 1.96B | 52.85% |
| Dec 29, 2023 | 1.28B | 11.06% |
| Dec 30, 2022 | 1.15B | -14.36% |
| Dec 30, 2021 | 1.35B | -0.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 138.33B |
| Getinge AB | 52.31B |
| Sectra AB | 50.63B |
| Camurus AB | 32.09B |
| Cereno Scientific AB | 1.89B |
| Surgical Science Sweden AB | 1.71B |
| Carasent AB | 1.55B |
| EQL Pharma AB | 1.50B |